Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (3): 338-347.doi: 10.19982/j.issn.1000-6621.20240508
• Original Articles • Previous Articles Next Articles
Zhang Mengdi1, Wang Qiqi2, Wang Xin1, Zheng Wenjing2, Sun Wenshan1, Xiao Yiran2, Guo Xiaomin3, Liu Jianjun4, Huang Fei5(), Yao Hongyan1(
)
Received:
2024-11-15
Online:
2025-03-10
Published:
2025-02-27
Contact:
Huang Fei, Email: Supported by:
CLC Number:
Zhang Mengdi, Wang Qiqi, Wang Xin, Zheng Wenjing, Sun Wenshan, Xiao Yiran, Guo Xiaomin, Liu Jianjun, Huang Fei, Yao Hongyan. Study on pulmonary tuberculosis disease burden in the elderly aged 60 and above in China, 2005—2020[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 338-347. doi: 10.19982/j.issn.1000-6621.20240508
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20240508
年份 | 发病率(/10万) | 患病率(/10万) | 死亡率(/10万) | |||
---|---|---|---|---|---|---|
粗率 | 标化率 | 粗率 | 标化率 | 粗率 | 标化率 | |
2005 | 177.50 | 174.60 | 1128.54 | 1117.00 | 35.21 | 35.44 |
2006 | 184.48 | 182.10 | 1219.58 | 1213.71 | 21.32 | 21.36 |
2007 | 191.00 | 189.22 | 1278.58 | 1277.65 | 18.85 | 18.90 |
2008 | 183.45 | 182.31 | 1241.79 | 1245.10 | 17.19 | 17.13 |
2009 | 167.25 | 166.77 | 1134.63 | 1139.21 | 16.18 | 16.74 |
2010 | 156.61 | 156.64 | 1058.56 | 1067.77 | 15.05 | 16.16 |
2011 | 140.80 | 140.44 | 974.87 | 974.83 | 13.65 | 14.31 |
2012 | 142.23 | 142.39 | 996.07 | 998.95 | 13.24 | 13.19 |
2013 | 134.97 | 135.48 | 951.10 | 957.51 | 10.71 | 10.77 |
2014 | 129.91 | 130.67 | 924.26 | 929.96 | 9.59 | 9.61 |
2015 | 131.24 | 131.98 | 913.84 | 919.53 | 9.85 | 9.86 |
2016 | 119.72 | 119.93 | 856.99 | 851.42 | 9.33 | 9.09 |
2017 | 121.83 | 122.00 | 858.60 | 851.67 | 8.82 | 8.59 |
2018 | 124.08 | 124.20 | 894.64 | 880.53 | 8.67 | 8.34 |
2019 | 103.34 | 104.34 | 735.91 | 747.54 | 7.63 | 7.89 |
2020 | 84.37 | 84.73 | 602.15 | 605.60 | 6.63 | 6.67 |
合计 | 137.97 | 142.99 | 954.06 | 986.12 | 10.38 | 14.00 |
AAPC(%) | -4.74 | -4.59 | -4.06 | -3.90 | -10.02 | -10.11 |
t值 | -6.098 | -5.812 | -8.438 | -7.222 | -7.348 | -7.105 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
年份 | DALYs (人年) | 标化DALYs 率(/10万) | YLLs(人年) | YLDs(人年) | ||
---|---|---|---|---|---|---|
数值 | 占比(%) | 数值 | 占比(%) | |||
2005 | 1392947.23 | 972.90 | 962489.86 | 69.10 | 430457.44 | 30.90 |
2006 | 1073136.68 | 731.02 | 601373.24 | 56.04 | 471763.39 | 43.96 |
2007 | 1046453.71 | 699.16 | 539560.81 | 51.56 | 506892.95 | 48.44 |
2008 | 1005611.78 | 655.40 | 504695.31 | 50.19 | 500916.43 | 49.81 |
2009 | 949081.95 | 608.51 | 480771.65 | 50.66 | 468310.34 | 49.34 |
2010 | 917919.43 | 575.29 | 467674.81 | 50.95 | 450244.62 | 49.05 |
2011 | 917542.41 | 527.48 | 464486.15 | 50.62 | 453056.26 | 49.38 |
2012 | 938564.59 | 517.32 | 461590.26 | 49.18 | 476974.36 | 50.82 |
2013 | 842868.06 | 456.84 | 378043.34 | 44.85 | 464824.76 | 55.15 |
2014 | 814841.31 | 425.57 | 346423.72 | 42.51 | 468417.59 | 57.49 |
2015 | 823902.42 | 425.52 | 355855.88 | 43.19 | 468046.55 | 56.81 |
2016 | 834941.38 | 393.30 | 360135.05 | 43.13 | 474806.34 | 56.87 |
2017 | 830763.22 | 387.26 | 352122.11 | 42.39 | 478641.13 | 57.61 |
2018 | 882067.97 | 387.75 | 357175.30 | 40.49 | 524892.72 | 59.51 |
2019 | 812589.63 | 333.72 | 333587.74 | 41.05 | 479001.88 | 58.95 |
2020 | 701760.00 | 276.76 | 297586.83 | 42.41 | 404173.20 | 57.59 |
合计 | 14784991.77 | 523.36 | 7263572.06 | 48.02 | 7521419.96 | 51.98 |
AAPC(%) | -3.68 | -7.11 | -6.93 | -0.26 | ||
t值 | -3.647 | -8.470 | -5.878 | -0.428 | ||
P值 | <0.001 | <0.001 | <0.001 | 0.669 |
年份 | DALYs(人年) | 标化DALYs率 (/10万) | ||
---|---|---|---|---|
男性 | 女性 | 男性 | 女性 | |
2005 | 989740.25 | 403206.98 | 1433.14 | 549.10 |
2006 | 774600.17 | 298536.50 | 1117.61 | 390.57 |
2007 | 763134.72 | 283319.00 | 1065.14 | 367.62 |
2008 | 743058.89 | 262552.88 | 1010.14 | 331.39 |
2009 | 699222.88 | 249859.08 | 939.61 | 310.37 |
2010 | 659557.66 | 258361.76 | 870.21 | 312.32 |
2011 | 662184.50 | 255357.91 | 801.78 | 283.23 |
2012 | 664329.24 | 274235.36 | 752.92 | 295.95 |
2013 | 613707.57 | 229160.49 | 681.46 | 242.82 |
2014 | 600040.43 | 214800.91 | 641.47 | 218.97 |
2015 | 594301.05 | 229601.37 | 631.32 | 230.93 |
2016 | 598492.87 | 236448.55 | 579.64 | 216.36 |
2017 | 602677.14 | 228086.08 | 578.86 | 205.90 |
2018 | 629870.70 | 252197.28 | 571.55 | 213.82 |
2019 | 591765.63 | 220824.02 | 506.98 | 174.51 |
2020 | 515139.41 | 186620.64 | 426.85 | 140.20 |
合计 | 10701823.11 | 4083168.81 | 788.04 | 280.25 |
AAPC(%) | -3.58 | -3.94 | -7.08 | -7.36 |
t值 | -3.939 | -2.656 | -9.294 | -5.813 |
P值 | <0.001 | 0.008 | <0.001 | <0.001 |
年份 | DALYs(人年) | 标化DALYs率 (/10万) | DALYs(人年) | 标化DALYs率 (/10万) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
城市 | 农村 | 城市 | 农村 | 东部 | 中部 | 西部 | 东部 | 中部 | 西部 | |
2005 | 307114.92 | 1085832.31 | 653.98 | 1132.64 | 357043.17 | 465266.11 | 570637.95 | 598.41 | 1052.12 | 1449.44 |
2006 | 264390.69 | 808745.99 | 542.53 | 827.05 | 325836.65 | 362721.47 | 384578.56 | 531.77 | 799.37 | 949.74 |
2007 | 267352.49 | 779101.22 | 525.44 | 790.46 | 309256.51 | 339402.42 | 397794.78 | 496.78 | 738.31 | 955.87 |
2008 | 251284.91 | 754326.87 | 479.94 | 747.85 | 303816.09 | 325952.17 | 375843.52 | 474.25 | 691.20 | 890.02 |
2009 | 237705.39 | 711376.56 | 445.28 | 694.68 | 278883.41 | 304452.27 | 365746.27 | 427.63 | 636.76 | 853.65 |
2010 | 236645.87 | 681273.56 | 432.73 | 650.81 | 250422.91 | 281727.15 | 385769.37 | 375.85 | 575.87 | 879.95 |
2011 | 234776.38 | 682766.03 | 387.23 | 608.04 | 231756.64 | 285978.24 | 399807.53 | 317.56 | 527.89 | 859.64 |
2012 | 236752.75 | 701811.84 | 368.37 | 598.56 | 242229.02 | 284215.10 | 412120.47 | 319.93 | 500.77 | 835.70 |
2013 | 243285.46 | 599582.60 | 365.81 | 507.90 | 227832.25 | 276800.90 | 338234.91 | 296.35 | 480.08 | 674.64 |
2014 | 243165.52 | 571675.79 | 363.84 | 458.78 | 227119.80 | 282513.03 | 305208.48 | 286.01 | 470.31 | 583.32 |
2015 | 249810.66 | 574091.76 | 362.76 | 460.23 | 237283.01 | 273942.11 | 312677.30 | 293.59 | 451.32 | 595.18 |
2016 | 256856.35 | 578085.03 | 334.15 | 427.21 | 237607.75 | 265251.22 | 332082.41 | 268.18 | 398.80 | 576.45 |
2017 | 257509.26 | 573253.96 | 327.13 | 422.57 | 235832.91 | 261560.72 | 333369.59 | 258.14 | 385.42 | 596.01 |
2018 | 270155.69 | 611912.28 | 316.90 | 430.58 | 243094.63 | 262917.70 | 376055.64 | 250.40 | 366.79 | 635.87 |
2019 | 273849.57 | 538740.06 | 270.00 | 378.98 | 234325.46 | 259816.24 | 318447.93 | 223.71 | 343.38 | 503.54 |
2020 | 243370.63 | 458389.37 | 224.59 | 315.33 | 212123.12 | 221110.87 | 268526.01 | 194.04 | 281.90 | 406.45 |
合计 | 4074026.54 | 10710965.23 | 400.04 | 590.73 | 4154463.33 | 4753627.72 | 5876900.72 | 350.79 | 543.77 | 765.34 |
AAPC(%) | -0.79 | -4.64 | -6.54 | -6.89 | -2.93 | -4.12 | -2.64 | -7.07 | -7.63 | -6.04 |
t值 | -1.468 | -3.835 | -7.702 | -16.224 | -6.453 | -4.961 | -4.290 | -7.163 | -11.015 | -9.573 |
P值 | 0.142 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
[1] | World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024. |
[2] | 姜世闻. 重视老年人结核病防治工作. 结核病与肺部健康杂志, 2018, 7(3): 157-160. doi:10.3969/j.issn.2095-3755.2018.03.002. |
[3] |
Donald PR, Marais BJ, Barry CE 3rd. Age and the epidemiology and pathogenesis of tuberculosis. Lancet, 2010, 375(9729): 1852-1854. doi:10.1016/S0140-6736(10)60580-6.
pmid: 20488519 |
[4] |
Rajagopalan S. Tuberculosis in Older Adults. Clin Geriatr Med, 2016, 32(3): 479-491. doi:10.1016/j.cger.2016.02.006.
pmid: 27394018 |
[5] | Verguet S, Chakrabarti A. Examining the computation of the underlying components of DALYs. Health Policy Plan, 2023, 38(5): 648-654. doi:10.1093/heapol/czad017. |
[6] | 黄飞, 杜昕, 陈伟, 等. 中国结核病信息管理系统介绍. 中国数字医学, 2011, 6(10): 97-100. doi:10.3969/j.issn.1673-7571.2011.10.032. |
[7] | 王黎君. 完善中国死因监测系统提供基本公共卫生数据. 环境卫生学杂志, 2023, 13(8): 605-607. doi:10.13421/j.cnki.hjwsxzz.2023.08.006. |
[8] | Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models in the estimation of disease epidemiology. Bull World Health Organ, 2002, 80(8): 622-628. |
[9] | Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table[DB/OL]. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2021[2025-01-10]. https://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2019-gbd-2019-reference-life-table. |
[10] | 刘晓雪. 中国人群疾病伤残权重测算及影响因素研究. 武汉: 武汉大学, 2022. doi:10.27379/d.cnki.gwhdu.2022.001075. |
[11] | 戴萌娜, 袭燕, 尹文强, 等. 1990—2019年中国结核病疾病负担现状及趋势分析. 中国慢性病预防与控制, 2022, 30(10): 792-797. doi:10.16386/j.cjpccd.issn.1004-6194.2022.10.017. |
[12] |
Ding C, Wang S, Shangguan Y, et al. Epidemic Trends of Tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study. Infect Drug Resist, 2020, 13: 1663-1672. doi:10.2147/IDR.S249698.
pmid: 32606817 |
[13] | 张灿有, 陈卉, 张慧, 等. 2011—2020年全国65岁及以上老年人肺结核报告发病情况分析. 中华疾病控制杂志, 2022, 26(11): 1252-1258. doi:10.16462/j.cnki.zhjbkz.2022.11.003. |
[14] | 中华人民共和国卫生部, 中华人民共和国国家计划委员会, 中华人民共和国财政部. 国务院办公厅关于印发全国结核病防治规划(2001—2010年)的通知. 国办发〔2001〕75号. 2001-10-13. |
[15] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知. 国办发〔2011〕53号. 2011-11-17. |
[16] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 国办发〔2007〕16号. 2017-02-01. |
[17] | 宋媛媛, 李涛, 夏辉, 等. 1997—2023年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10): 1198-1208. doi:10.19982/j.issn.1000-6621.20240382. |
[18] | 陆伟, 周扬, 刘剑君. 新中国成立70年来我国结核病防治工作的进展与成就. 中华疾病控制杂志, 2019, 23(7): 754-757, 762. doi:10.16462/j.cnki.zhjbkz.2019.07.003. |
[19] |
Huang F, Cheng S, Du X, et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J Am Med Inform Assoc, 2014, 21(5): 938-941. doi:10.1136/amiajnl-2013-002001.
pmid: 24326537 |
[20] |
Zhang Y, Zhang L, Gao W, et al. The impact of COVID-19 pandemic on reported tuberculosis incidence and mortality in China: An interrupted time series analysis. J Glob Health, 2023, 13: 06043. doi:10.7189/jogh.13.06043.
pmid: 37824176 |
[21] | Xu J, Wang Y, Liu F, et al. Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic. J Infect, 2023, 86(2): 154-225. doi:10.1016/j.jinf.2022.12.008. |
[22] | Dong Z, Wang Q, Yu S, et al. Application of Disability-Adjusted Life Years to Evaluate the Burden and Trend of Tuberculosis-China, 1990—2019. China CDC Wkly, 2022, 4(11): 220-225. doi:10.46234/ccdcw2022.051. |
[23] | 滕人聪, 李涛, 李玉红, 等. 2015—2021年全国65岁及以上老年肺结核患者登记情况分析. 中国防痨杂志, 2023, 45(4): 367-371. doi:10.19982/j.issn.1000-6621.20220494. |
[24] | 许群, 乌正赉, 金水高, 等. 初治涂阳肺结核病人及其传染性所致疾病负担的评价方法研究. 卫生研究, 2003, 32(6): 558-561. doi:10.3969/j.issn.1000-8020.2003.06.010. |
[25] |
Che B, Zheng X, Chen B, et al. The temporal trend of tuberculosis burden in an aging population in China: a secondary data analysis from the GBD 2019. BMC Pulm Med, 2024, 24(1): 476. doi:10.1186/s12890-024-03293-2.
pmid: 39334014 |
[26] | Horton KC, MacPherson P, Houben RM, et al. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. PLoS Med, 2016, 13(9): e1002119. doi:10.1371/journal.pmed.1002119. |
[27] |
Hertz D, Schneider B. Sex differences in tuberculosis. Semin Immunopathol, 2019, 41(2): 225-237. doi:10.1007/s00281-018-0725-6.
pmid: 30361803 |
[28] | Zhao Y, Su B, Tian Y, et al. Trends and Patterns of Respiratory Tuberculosis Mortality in Rural and Urban-China, 1987—2021. China CDC Wkly, 2023, 5(42): 938-942. doi:10.46234/ccdcw2023.176. |
[29] | Li M, Lu L, Guo M, et al. Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China. Emerg Microbes Infect, 2023, 12(1): 2192301. doi:10.1080/22221751.2023.2192301. |
[30] | Zhang Q, Song W, Liu S, et al. An Ecological Study of Tuberculosis Incidence in China, From 2002 to 2018. Front Public Health, 2021, 9: 766362. doi:10.3389/fpubh.2021.766362. |
[31] | 祖力卡提阿衣·阿布都拉, 王新旗, 赵珍, 等. 2015—2019年新疆维吾尔自治区肺结核流行病学特征分析. 疾病监测, 2021, 36(11): 1138-1141. doi:10.3784/jbjc.202107010375. |
[32] | 李政, 方乐天, 胡明, 等. 2006—2021年中国居民结核病死亡情况的流行特征分析与预测. 中华流行病学杂志, 2024, 45(6): 824-832. doi:10.3760/cma.j.cn112338-20231114-00286. |
[33] | 中华人民共和国民政部, 全国老龄办. 2023年度国家老龄事业发展公报. 2024-10-11. |
[34] | 中华人民共和国国家卫生健康委员会宣传司. 国家卫生健康委员会2022年9月20日新闻发布会文字实录[EB/OL]. [2025-02-25]. http://www.nhc.gov.cn/xcs/s3574/202209/ee4dc20368b440a49d270a228f5b0ac1.shtml. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||